Historical review from 2026-10-13. Current price and availability are unconfirmed; check the original marketplace.
isMalicious delivers $1.9K/mo revenue with an exceptional 95% profit margin and a highly attractive 1.6x annual profit multiple—well below the 2.5–3.5x range typical for stable software businesses. TrustMRR's platform verification (dataQualityScore 100, verified flag) adds credibility to the financials. The 19-month operating history and security/threat-intelligence niche suggest a focused, defensible product. A buyer should confirm customer count, retention/churn, and revenue concentration to fully evaluate cash-flow durability and growth potential.
Buying isMalicious acquires $1.8K/mo verified profit with 95% margins and an established presence in the security threat-intelligence niche—a customer segment that requires domain credibility and integration maturity (STIX/TAXII, OpenCTI, MCP server support). Building an MVP threat-intelligence API with equivalent integrations would cost $8–18K in AI-assisted development and 10 weeks of focused work, but would lack the installed customer base, retention history, and market validation that justify the 1.6x multiple. The real value lies in traction (proven paying customers in a niche vertical) and operational efficiency (95% margins), not software replacement cost. A buyer purchasing this asset gains immediate, profitable revenue and a foundation for upsell within the security community, rather than speculative customer acquisition from scratch.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
isMalicious is a suite of tools of cyberthreats intelligence, SIEM threatl intelligence API, STIX / TAXII, OpenCTI, MCP server.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.